Financial considerations in the conduct of multi-centre randomised controlled trials

evidence from a qualitative study

Claire Snowdon, Diana R. Elbourne, Jo Garcia, Marion K. Campbell, Vikki Ann Entwistle, David Francis, Adrian M. Grant, Rosemary C. Knight, Alison M. McDonald, Ian Roberts

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Securing and managing finances for multicentre randomised controlled trials is a highly complex activity which is rarely considered in the research literature. This paper describes the process of financial negotiation and the impact of financial considerations in four UK multicentre trials. These trials had met, or were on schedule to meet, recruitment targets agreed with their public- sector funders. The trials were considered within a larger study examining factors which might be associated with trial recruitment ( STEPS). Methods: In-depth semi-structured telephone interviews were conducted in 2003-04 with 45 individuals with various responsibilities to one of the four trials. Interviewees were recruited through purposive and then snowball sampling. Interview transcripts were analysed with the assistance of the qualitative package Atlas-ti. Results: The data suggest that the UK system of dividing funds into research, treatment and NHS support costs brought the trial teams into complicated negotiations with multiple funders. The divisions were somewhat malleable and the funding system was used differently in each trial. The fact that all funders had the potential to influence and shape the trials considered here was an important issue as the perspectives of applicants and funders could diverge. The extent and range of industry involvement in non-industry-led trials was striking. Three broad periods of financial work ( foundation, maintenance, and resourcing completion) were identified. From development to completion of a trial, the trialists had to be resourceful and flexible, adapting to changing internal and external circumstances. In each period, trialists and collaborators could face changing costs and challenges. Each trial extended the recruitment period; three required funding extensions from MRC or HTA. Conclusion: This study highlights complex financial aspects of planning and conducting trials, especially where multiple funders are involved. Recognition of the importance of financial stability and of the need for appropriate training in this area should be paralleled by further similar research with a broader range of trials, aimed at understanding and facilitating the conduct of clinical research.

Original languageEnglish
Number of pages18
JournalTrials
Volume7
Issue number34
DOIs
Publication statusPublished - 2006

Keywords

  • cancer clinical-trials
  • pharmaceutical-industry
  • biomedical-research
  • harmful impact
  • breast-cancer
  • telephone interviews
  • medical-research
  • palliative care
  • United-Kingdom
  • recruitment

Cite this

Financial considerations in the conduct of multi-centre randomised controlled trials : evidence from a qualitative study. / Snowdon, Claire; Elbourne, Diana R.; Garcia, Jo; Campbell, Marion K.; Entwistle, Vikki Ann; Francis, David; Grant, Adrian M.; Knight, Rosemary C.; McDonald, Alison M.; Roberts, Ian.

In: Trials, Vol. 7, No. 34, 2006.

Research output: Contribution to journalArticle

Snowdon, Claire ; Elbourne, Diana R. ; Garcia, Jo ; Campbell, Marion K. ; Entwistle, Vikki Ann ; Francis, David ; Grant, Adrian M. ; Knight, Rosemary C. ; McDonald, Alison M. ; Roberts, Ian. / Financial considerations in the conduct of multi-centre randomised controlled trials : evidence from a qualitative study. In: Trials. 2006 ; Vol. 7, No. 34.
@article{6b6b4fc34ad74cb6981af6bdff15bdf0,
title = "Financial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative study",
abstract = "Background: Securing and managing finances for multicentre randomised controlled trials is a highly complex activity which is rarely considered in the research literature. This paper describes the process of financial negotiation and the impact of financial considerations in four UK multicentre trials. These trials had met, or were on schedule to meet, recruitment targets agreed with their public- sector funders. The trials were considered within a larger study examining factors which might be associated with trial recruitment ( STEPS). Methods: In-depth semi-structured telephone interviews were conducted in 2003-04 with 45 individuals with various responsibilities to one of the four trials. Interviewees were recruited through purposive and then snowball sampling. Interview transcripts were analysed with the assistance of the qualitative package Atlas-ti. Results: The data suggest that the UK system of dividing funds into research, treatment and NHS support costs brought the trial teams into complicated negotiations with multiple funders. The divisions were somewhat malleable and the funding system was used differently in each trial. The fact that all funders had the potential to influence and shape the trials considered here was an important issue as the perspectives of applicants and funders could diverge. The extent and range of industry involvement in non-industry-led trials was striking. Three broad periods of financial work ( foundation, maintenance, and resourcing completion) were identified. From development to completion of a trial, the trialists had to be resourceful and flexible, adapting to changing internal and external circumstances. In each period, trialists and collaborators could face changing costs and challenges. Each trial extended the recruitment period; three required funding extensions from MRC or HTA. Conclusion: This study highlights complex financial aspects of planning and conducting trials, especially where multiple funders are involved. Recognition of the importance of financial stability and of the need for appropriate training in this area should be paralleled by further similar research with a broader range of trials, aimed at understanding and facilitating the conduct of clinical research.",
keywords = "cancer clinical-trials, pharmaceutical-industry, biomedical-research, harmful impact, breast-cancer, telephone interviews, medical-research, palliative care, United-Kingdom, recruitment",
author = "Claire Snowdon and Elbourne, {Diana R.} and Jo Garcia and Campbell, {Marion K.} and Entwistle, {Vikki Ann} and David Francis and Grant, {Adrian M.} and Knight, {Rosemary C.} and McDonald, {Alison M.} and Ian Roberts",
year = "2006",
doi = "10.1186/1745-6215-7-34",
language = "English",
volume = "7",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",
number = "34",

}

TY - JOUR

T1 - Financial considerations in the conduct of multi-centre randomised controlled trials

T2 - evidence from a qualitative study

AU - Snowdon, Claire

AU - Elbourne, Diana R.

AU - Garcia, Jo

AU - Campbell, Marion K.

AU - Entwistle, Vikki Ann

AU - Francis, David

AU - Grant, Adrian M.

AU - Knight, Rosemary C.

AU - McDonald, Alison M.

AU - Roberts, Ian

PY - 2006

Y1 - 2006

N2 - Background: Securing and managing finances for multicentre randomised controlled trials is a highly complex activity which is rarely considered in the research literature. This paper describes the process of financial negotiation and the impact of financial considerations in four UK multicentre trials. These trials had met, or were on schedule to meet, recruitment targets agreed with their public- sector funders. The trials were considered within a larger study examining factors which might be associated with trial recruitment ( STEPS). Methods: In-depth semi-structured telephone interviews were conducted in 2003-04 with 45 individuals with various responsibilities to one of the four trials. Interviewees were recruited through purposive and then snowball sampling. Interview transcripts were analysed with the assistance of the qualitative package Atlas-ti. Results: The data suggest that the UK system of dividing funds into research, treatment and NHS support costs brought the trial teams into complicated negotiations with multiple funders. The divisions were somewhat malleable and the funding system was used differently in each trial. The fact that all funders had the potential to influence and shape the trials considered here was an important issue as the perspectives of applicants and funders could diverge. The extent and range of industry involvement in non-industry-led trials was striking. Three broad periods of financial work ( foundation, maintenance, and resourcing completion) were identified. From development to completion of a trial, the trialists had to be resourceful and flexible, adapting to changing internal and external circumstances. In each period, trialists and collaborators could face changing costs and challenges. Each trial extended the recruitment period; three required funding extensions from MRC or HTA. Conclusion: This study highlights complex financial aspects of planning and conducting trials, especially where multiple funders are involved. Recognition of the importance of financial stability and of the need for appropriate training in this area should be paralleled by further similar research with a broader range of trials, aimed at understanding and facilitating the conduct of clinical research.

AB - Background: Securing and managing finances for multicentre randomised controlled trials is a highly complex activity which is rarely considered in the research literature. This paper describes the process of financial negotiation and the impact of financial considerations in four UK multicentre trials. These trials had met, or were on schedule to meet, recruitment targets agreed with their public- sector funders. The trials were considered within a larger study examining factors which might be associated with trial recruitment ( STEPS). Methods: In-depth semi-structured telephone interviews were conducted in 2003-04 with 45 individuals with various responsibilities to one of the four trials. Interviewees were recruited through purposive and then snowball sampling. Interview transcripts were analysed with the assistance of the qualitative package Atlas-ti. Results: The data suggest that the UK system of dividing funds into research, treatment and NHS support costs brought the trial teams into complicated negotiations with multiple funders. The divisions were somewhat malleable and the funding system was used differently in each trial. The fact that all funders had the potential to influence and shape the trials considered here was an important issue as the perspectives of applicants and funders could diverge. The extent and range of industry involvement in non-industry-led trials was striking. Three broad periods of financial work ( foundation, maintenance, and resourcing completion) were identified. From development to completion of a trial, the trialists had to be resourceful and flexible, adapting to changing internal and external circumstances. In each period, trialists and collaborators could face changing costs and challenges. Each trial extended the recruitment period; three required funding extensions from MRC or HTA. Conclusion: This study highlights complex financial aspects of planning and conducting trials, especially where multiple funders are involved. Recognition of the importance of financial stability and of the need for appropriate training in this area should be paralleled by further similar research with a broader range of trials, aimed at understanding and facilitating the conduct of clinical research.

KW - cancer clinical-trials

KW - pharmaceutical-industry

KW - biomedical-research

KW - harmful impact

KW - breast-cancer

KW - telephone interviews

KW - medical-research

KW - palliative care

KW - United-Kingdom

KW - recruitment

U2 - 10.1186/1745-6215-7-34

DO - 10.1186/1745-6215-7-34

M3 - Article

VL - 7

JO - Trials

JF - Trials

SN - 1745-6215

IS - 34

ER -